NATALIE TRUJILLO: Open Payments
NPI 1205307436 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 66 payments from 18 companies in 2025. Trend: 2023 $83 · 2024 $207 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $362 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Lilly USA, LLC | 6 | $98 |
| Eisai Inc. | 3 | $85 |
| Viatris Specialty LLC | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Astellas Pharma US Inc | 3 | $61 |
| PFIZER INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $42 |
Products named: VRAYLAR, QULIPTA, AIRSUPRA, Leqembi, YUPELRI, MOUNJARO, CAPLYTA, Veozah.
Industry payments across AZ — which companies pay providers there.
